drugset / Trial / NCT00012181
Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
NaSingle-groupOpen-labelTreatment
Summary
Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Phase I trial to study the effectiveness of flavopiridol in treating children who have relapsed or refractory solid tumors or lymphoma.
Timeline
- Start
- 2001-04
- Primary completion
- 2005-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | alvocidib | Small molecule | — | Intravenous |
Indications
Burkitt lymphoma
Ewing sarcoma/peripheral primitive neuroectodermal tumor
Hodgkins lymphoma
cerebellar astrocytoma
childhood brain stem glioma
childhood ependymoma
childhood kidney neoplasm
childhood medulloblastoma
liver and intrahepatic bile duct neoplasm
malignant childhood germ cell neoplasm
neuroblastoma
optic pathway glioma
osteosarcoma
precursor lymphoblastic lymphoma/leukemia
retinoblastoma
rhabdomyosarcoma
supratentorial primitive neuroectodermal tumor